Compound ID | 2611
Synonym(s): Methacycline | methamycin | andramycin | GS-2876
Class: Tetracycline
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Protein synthesis inhibitor. Prevents access to aminoacyl-tRNA binding site |
| Target Pathogen: | Broad-spectrum activity |
| Description: | Semisynthetic compound derived from oxytetracycline; with reduced absorption (administered orally); reduced usefulness due to emergence of tetracycline resistance William, M., et al. "Comparison of two new tetracycline with tetracycline and demetyhlchlortetracycline."Program and Abstracts of the interscience science Conference on Antimicrobial Agents and Chemotherapy. 1961. |
| Institute where first reported: | Medpointe Pharmaceuticals; University of Washington |
| Year first mentioned: | 1961 |
| Highest developmental phase: | Approved |
| Development status: | Discontinued |
| Reason Dropped: | Small serum activity afer 24 hours compared with tetracycline |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/54675785 |
| Guide to Pharmacology: | metacycline |
| Citations: |
|
| Patent: | US3966808A |